Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2025-12-26 @ 2:41 PM
NCT ID:
NCT00125606
Eligibility Criteria:
Inclusion Criteria:
* Patients with AML in second complete remission
* HLA-identical related (HLA \* A, B, and DR) or HLA-compatible unrelated donor with maximum of one Ag mismatch
* Ages 18-60 years
* Written informed consent from the patient
* Written informed consent from the donor
* No major organ dysfunction
Exclusion Criteria:
* Cardiac failure (New York Heart Association \[NYHA\] grade II-IV)
* Renal failure (creatinine \> 2.0 mg/dl)
* Hepatic failure (total bilirubin \> 3 mg/dl)
* Severe neurological/psychiatric disorder
* Previous allogeneic HSCT
* Contra-indications for used drugs
* HIV infection
* Non-compliance to processing of personal data according to the protocol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00125606
Study Brief:
Protocol Section:
NCT00125606